UNSPSC 51101684: Spirazine or spirotriazine

This classification denotes an antiparasitic agent with the molecular formula C15H20ClN5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WV516JUV0B, chemically known as 1,3,5-triazaspiro(5.5)undeca-1,3-diene, 2,4-diamino-5-(p-chlorophenyl)-9-methyl- but generally known as spirazine, which bears US NIH Compound Identifier 210321. European Medicines Agency schedules Spirazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10622MIG. The term SPIRAZINE is an International Non-Proprietary Name.

SPIRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Spirazine or spirotriazine bears US NLM identifiers UMLS ID C2827337 and NCI Concept Code C84180. SMILES: CLC1CCC(N2C3(N=C(N=C2N)N)CCC(CC3)C)CC1.

UNSPSC 51101684 Spirazine or spirotriazine is a Commodity code that in recent state and local procurement activity names pharmaceutical products including anti-infective tablets, naloxone, and drug deactivation systems — rather than the narrow chemical compound suggested by its abstract designation. State and local buying under this code spans health departments, county public-health agencies, and community-health systems acquiring pharmaceutical inventory for emergency preparedness, overdose response, and strategic national stockpile programs. The Illinois Department of Public Health and Seminole County, Florida represent the issuing-body mix, with health departments and county public-health authorities as the primary buyers. Procurements take the form of competitive bids and piggyback awards through multi-state purchasing consortia such as MMCAP Infuse, which allow agencies to leverage volume and pre-negotiated pricing.

Illinois and Florida show recent activity under this code. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026 through an Invitation for Bid process for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, with a 12-month initial term and renewal options through year three. Seminole County, Florida released an IFB on June 30, 2026 seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option; the response deadline was July 26, 2026 at 2:00 pm. Both procurements required vendors to submit bids electronically, include all shipping and delivery costs in pricing, and comply with drug-free workplace and E-Verify requirements.